| 000 | 01306 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250518022831.0 | ||
| 264 | 0 | _c20191226 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1521-0103 | ||
| 024 | 7 |
_a10.1124/jpet.118.256081 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLewis, Mark H | |
| 245 | 0 | 0 |
_aTargeting Dopamine D _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _c04 2019 |
||
| 300 |
_a88-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aPeromyscus |
| 650 | 0 | 4 |
_aReceptor, Adenosine A2A _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, Metabotropic Glutamate 5 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aPrimiani, Christopher T | |
| 700 | 1 | _aMuehlmann, Amber M | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 369 _gno. 1 _gp. 88-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.118.256081 _zAvailable from publisher's website |
| 999 |
_c29354149 _d29354149 |
||